| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,897 |
7,315 |
$456K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,384 |
3,476 |
$325K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
15,442 |
5,013 |
$209K |
| J3490 |
Unclassified drugs |
2,200 |
1,318 |
$195K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,677 |
1,326 |
$193K |
| A9270 |
Non-covered item or service |
2,431 |
442 |
$83K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,301 |
1,149 |
$36K |
| 80053 |
Comprehensive metabolic panel |
239 |
217 |
$27K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
589 |
579 |
$20K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
144 |
144 |
$18K |
| 01967 |
Neuraxial labor analgesia/anesthesia for planned vaginal delivery |
158 |
149 |
$15K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,463 |
142 |
$15K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
46 |
42 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
612 |
592 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
258 |
121 |
$5K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
778 |
685 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
81 |
48 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
108 |
108 |
$3K |
| Q3014 |
Telehealth originating site facility fee |
105 |
48 |
$3K |
| 36416 |
|
45 |
42 |
$2K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
14 |
14 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
66 |
25 |
$1K |
| 01480 |
|
21 |
13 |
$1K |
| 81001 |
|
27 |
26 |
$1K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
12 |
12 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
73 |
71 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
32 |
32 |
$984.58 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$750.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12 |
12 |
$721.10 |
| G0008 |
Administration of influenza virus vaccine |
120 |
24 |
$685.42 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
45 |
13 |
$668.31 |
| 11721 |
|
26 |
12 |
$342.04 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
507 |
452 |
$335.81 |
| 87081 |
|
218 |
210 |
$36.18 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
58 |
15 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
16 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
53 |
24 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
14 |
14 |
$0.00 |
| 90656 |
|
12 |
12 |
$0.00 |
| 86140 |
|
31 |
28 |
$0.00 |